Navigation Links
Sihuan Pharmaceutical Achieves Important R&D Breakthrough
Date:3/11/2012

HONG KONG, March 11, 2012 /PRNewswire-Asia/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company and the largest cardio-cerebral vascular drug franchise in China by market share, announced today that its application to register Tylerdipine Hydrochloride, the Company's first international and innovative anti-hypertensive drug developed by its in-house research and development ("R&D") team, has been officially accepted by the Chinese State Food and Drug Administration ("SFDA") (Acceptance No.: CXHL1100774 and CXHL1100775). The application acceptance is an important step and significant achievement for the Company and comes on top of its approval to conduct clinical trials for its internally developed anti-infective drug Apapenem Carbapenems earlier this year.

Tylerdipine Hydrochloride, a class 1.1 chemical drug which is an innovative patented calcium channel blocker for the treatment of hypertension, features a novel molecular structure and independent intellectual property right. As the Company's first international and innovative drug to apply for both domestic and overseas registration, the Company aims to apply for Investigational New Drug ("IND") with the U.S. Food and Drug Administration ("FDA") in 2012. The drug is expected to receive permission for clinical trial in China by the end of 2013.

Results from pre-clinical studies have shown that Tylerdipine Hydrochloride is a superior agent in blocking L-type and T-type calcium channels. The Company believes Tylerdipine Hydrochloride can effectively curb hypertension in clinical practice while offering protection to important organs such as the heart and kidneys. Meanwhile, it would significantly reduce the cost of treating hypertension, presenting high value in clinical practice. More importantly, Tylerdipine Hydrochloride is more effective than the current anti-hypertension drugs, based on certain pr
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition
2. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
3. Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare Conference
4. S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
5. Questcor Pharmaceuticals to Present at the 24th Annual ROTH Conference on March 12, 2012
6. Patented Protection Against Counterfeit Pharmaceuticals and Retail Fraud. ICAP Patent Brokerage Announces for Auction a Patented System for Verification of Purchase and Product Legality
7. Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing
8. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
9. The Outlook for Pharmaceuticals in Western Europe
10. ASLAN Pharmaceuticals Selects PharmaNet/i3 as Strategic Partner For Oncology Development
11. Access Pharmaceuticals Updates MuGard.com With New Product Testimonial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 RoundTable Healthcare Partners ("RoundTable"), ... the healthcare industry, announced today that it has ... the "Company"). Founded in 1969 in ... a manufacturer of paper-based barrier products. Through a ... has expanded its product offering to include a ...
(Date:7/6/2015)... , July 6, 2015   BioClinica®, ... technology provider, today announced that it has acquired ... MediciGroup ® , Inc. (Medici).  The acquisition includes ... Patients, LLC.  Medici also provides a lost-to-follow-up patient ... patients globally.  Together with Medici, BioClinica ...
(Date:7/6/2015)... PARK, Calif. , July 6, 2015  Protiviti, ... its 2015 Internal Auditing around the World ... Protiviti has analyzed and reported on the evolution of ... companies from around the globe as a means to ... deeper understanding of this strategic business function. ...
Breaking Medicine Technology:RoundTable Healthcare Partners Acquires TIDI Products 2RoundTable Healthcare Partners Acquires TIDI Products 3BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2
... been learned in the decade since the first results ... July 9, 2002. The WHI was the largest and ... The 27,000 women were prescribed estrogen-alone therapy, estrogen-progestogen therapy, ... Researchers expected to find that hormones prevented ...
...  The Medical Letter – recognized since 1959 as the ... announces the launch of its new blog: More@MedLetter | ... can be found at blog.medicalletter.org . ... perspectives and analysis of the issues reported in our ...
Cached Medicine Technology:NAMS Journal Menopause Reflects on the WHI 10 Years Later 2
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Health care ... the ability of the medical field to access and use this “Big Data” to ... MD, President and Chief Executive Officer of the Mount Sinai Health System in New ...
(Date:7/6/2015)... ... ... In a split second, breaking a bone can cause loss of freedom ... through the bone health screenings conducted by American Bone Health trained Peer Educators during ... need this information to remain independent and strong for many more years,” according to ...
(Date:7/6/2015)... ... ... World renowned Los Angeles facial plastic surgeon , Dr. Paul Nassif, ... solutions. Individuals that want to make multiple changes to their facial appearance are able ... of their needs. , "Anytime I see an opportunity to change the life ...
(Date:7/6/2015)... ... July 06, 2015 , ... Orthopaedic & Spine ... 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on Tuesday, ... The procedure was an L5-S1 posterior lumbar interbody fusion on a 69 year ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Path of Least Resistance: The Evolution of ... with the U.S. economy over the past 40 years. The book explores the evolution ... ways, the book is a time capsule that chronicles the economic development of the ...
Breaking Medicine News(10 mins):Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2
... , , , ... Annual World Medical Tourism & Global Health Congress, the largest ... record increase in attendance this coming October 26-28th 2009 in ... countries confirmed participation. Up to 5,000 private one-on-one networking ...
... , , , ... of the U.S. compression therapy market is necessitating the introduction ... using the concept of evidence-based medicine to educate physicians and ... consumers has spurred the demand for early diagnosis and preventive ...
... An increasing number of heart failure patients are treated ... therapy (CRT). Recently completed and ongoing clinical trials ... growing number of CRT patients, in need of individualised ... simultaneous need for increased efficiency as well as enhanced ...
... , , LOS ANGELES, ... revealed a new site design today as well as features ... a journey towards conception. , , FertilityTies ... which offers support and answers to those faced with infertility ...
... , NATICK, Mass. and BARCELONA, Sept. ... ) today announced long-term data from the Prevention of ... results found that implantable cardioverter defibrillators (ICDs) were associated ... (p=0.053) when implanted in patients following myocardial infarction (heart ...
... , ALISO VIEJO, Calif., Sept. 1 ... services resource for pathologists, oncologists and the pharmaceutical industry, today announced ... investor conferences in New York City. , , ... & Renshaw 11th Annual Healthcare Conference at 2:50 pm EDT on ...
Cached Medicine News:Health News:World's Largest Medical Tourism and Global Healthcare Conference, October 26-28th, Announces Record Attendance, Distinguished Speakers and Sponsors 2Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 2Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 3Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 4Health News:FertilityTies, Social Network for the Fertility-Focused Unveils New Site Design, Unique Features to Help Patients Find Fertility Doctors & More 2Health News:PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors 2Health News:PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors 3Health News:Clarient to Present at Upcoming Investment Conferences in New York City 2
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0540, 0887....
For use with catalog #0540....
For use with catalog #0454....
Medicine Products: